$158,000 ALS drug pulled from market after failing in large clinical trial
The drug is now unavailable to new patients; its maker to lay off 70% of employees.


Ars Technica
$158,000 ALS drug pulled from market after failing in large clinical trial
The drug is now unavailable to new patients; its maker to lay off 70% of employees.


